Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Brightling (Leicester (Leicestershire), United Kingdom), M. Gaga (Athens, Greece), H. Inoue (Kagoshima, Japan), J. Li (Guangzhou, China), J. Maspero (Buenos Aries, Argentina), S. Wenzel (Pittsburg, United States of America), S. Maitra (Hyderabad, India), D. Lawrence (Basel, Switzerland), F. Brockhaus (Basel, Sweden), T. Lehmann (Basel, Switzerland), C. Brindicci (Basel, Switzerland), B. Knorr (East Hanover, United States of America), E. Bleecker (Tucson, United States of America). Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma. 4614

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Predictive value of FeNO in patients with non-specific respiratory symptoms: a randomised controlled trial Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Late Breaking Abstract - The impact of regular bisoprolol on recovery with salbutamol in asthma; a double-blind randomised controlled trial Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Late Breaking Abstract - Telerehabilitation compared to centre-based pulmonary rehabilitation: a randomised controlled equivalence trial. Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Late Breaking Abstract - Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children: a randomized controlled trial Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Late Breaking Abstract - CPAP treatment in the very elderly with Ostructive Sleep Apnea. Pooled results from two multicenter randomized controlled trials Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 Late Breaking Abstract - Efficacy and safety of eliapixant in refractory chronic cough: Results of the PAGANINI 12-week, randomized, placebo-controlled Phase 2b study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Effect on asthma control using a novel digital self-management system: a physician blinded randomised controlled cross-over pilot trial Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Targeting treatable traits in severe asthma: a randomised controlled trial Source: Eur Respir J, 55 (3) 1901509; 10.1183/13993003.01509-2019 Year: 2020 Late Breaking Abstract - Supplementation of iron in pulmonary hypertension (SIPHON): results from a randomised controlled crossover trial Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract: High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: A double-blind randomised controlled trial Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Roflumilast for stable COPD: Meta-analysis of randomized controlled trials Source: International Congress 2014 – Clinical presentations Year: 2014 Efficiency of physiotherapy with Caycedian Sophrology on children with asthma: a randomized controlled trial. Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure Year: 2018 Late Breaking Abstract - Long-term safety and efficacy of benralizumab in severe, uncontrolled asthma: first results of BORA, a randomized, Phase III extension study Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Effects of a new airway clearance technology in children with cystic fibrosis - A homecare randomized controlled trial Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Late Breaking Abstract - Tocilizumab in hospitalized patients with severe COVID-19: an open label, prospective study Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Preschool asthma - have randomised controlled trials provided clarity on management? Source: International Congress 2018 – Infectious agents and childhood asthma Year: 2018